GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » Unearned Premiums

Orphazyme AS (OCSE:ORPHA) Unearned Premiums


View and export this data going back to 2017. Start your Free Trial

What is Orphazyme AS Unearned Premiums?

Unearned Premiums only applies to insurance companies.


Orphazyme AS (OCSE:ORPHA) Business Description

Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).